Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

September 17, 2020
Open Access

Trial watch: TLR3 agonists in cancer therapy

Julie Le NaourErika Vacchelli
September 19, 2020
Open Access

Establishment and characterization of a new gastric cancer cell line, XGC-1

Cancer Cell International
Jigui PengJianchun Cai
September 17, 2020

Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy

Melissa BersanelliSebastiano Buti
September 18, 2020
Open Access

β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer

Caihong WangWei-Qiang Gao
September 21, 2020

Anti-phospholipid antibody may reduce endometrial receptivity during the window of embryo implantation

Journal of Gynecology Obstetrics and Human Reproduction
Xiaofang TanJie Wu
September 19, 2020

An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer

Expert Review of Clinical Pharmacology
Jeffrey A Rappaport, Scott A Waldman
September 16, 2020

Efficacy of BCG vaccine and Mitomycin C for the treatment of ocular squamous cell carcinoma in bovines

Research in Veterinary Science
Veena PodaralaRani Prameela Devalam
September 15, 2020

The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy

Cytokine & Growth Factor Reviews
Arthur DyerLen W Seymour
September 18, 2020

Experimental Human Pneumococcal Colonisation in Older Adults is Feasible and Safe, Not Immunogenic

American Journal of Respiratory and Critical Care Medicine
Hugh AdlerJamie Rylance
September 20, 2020

Cancer Immunoprevention: Challenges and Potential Opportunities for Use of Immune Checkpoint Inhibitors

Cancer Prevention Research
Altaf MohammedShizuko Sei
September 17, 2020
Open Access

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications

Giorgio FregaOliver Kepp
September 17, 2020
Open Access

Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer

International Journal of Molecular Sciences
Masanori OshiKazuaki Takabe
September 17, 2020
Open Access

Nuclear receptor FXR impairs SK-Hep-1 cell migration and invasion by inhibiting the Wnt/β-catenin signaling pathway

Oncology Letters
Qianqian LiXiongfei Huang
September 19, 2020

Mir-320b inhibits pancreatic cancer cell proliferation by targeting FOXM1

Current Pharmaceutical Biotechnology
Zhou JingyangZhou Wuyuan

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.


Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

© 2020 Meta ULC. All rights reserved